Sun Pharmaceutical announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, an immunotherapy and oncology company.

Celltrion Inc., a major South Korean biopharmaceutical firm, said Monday its biosimilar for asthma and other chronic allergic diseases has obtained approval for U.S. sales. The U.S. Food and Drug ...

A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

Interest in human use of ivermectin grew when people began taking it to prevent or treat COVID-19, despite the FDA and other ...

Both warnings letters were issued after multiple inspections and following failures to respond to FDA 483a forms issued at ...

Dr. Makary argues for more humility from the medical establishment and common sense when reviewing experimental drugs for ...

As earnings season begins, filings to the SEC point to uncertainty from the current administration as potential trouble for ...

HHS is one of the government's costliest federal agencies, with an annual budget of about $1.7 trillion, mostly going to ...

Of the states that do provide coverage for JAK inhibitors used to treat patients with alopecia, researchers found that prior ...

PTC Therapeutics could boost revenue with vatiquinone for Friedreich's ataxia. Find out why PTCT stock is poised for growth ...

The ruxolitinib cream met its primary end point as a treatment for prurigo nodularis in one phase 3 trial but fell short in ...